nodes	percent_of_prediction	percent_of_DWPC	metapath
Sevoflurane—CYP3A4—bone cancer	0.672	1	CbGaD
Sevoflurane—Anaphylactoid reaction—Cisplatin—bone cancer	0.00151	0.00768	CcSEcCtD
Sevoflurane—Hyperventilation—Epirubicin—bone cancer	0.0015	0.00764	CcSEcCtD
Sevoflurane—Hyperventilation—Doxorubicin—bone cancer	0.00139	0.00707	CcSEcCtD
Sevoflurane—Albuminuria—Epirubicin—bone cancer	0.00138	0.00704	CcSEcCtD
Sevoflurane—Amblyopia—Epirubicin—bone cancer	0.00134	0.00681	CcSEcCtD
Sevoflurane—Apnoea—Methotrexate—bone cancer	0.0013	0.00663	CcSEcCtD
Sevoflurane—Albuminuria—Doxorubicin—bone cancer	0.00128	0.00651	CcSEcCtD
Sevoflurane—Glycosuria—Epirubicin—bone cancer	0.00128	0.00649	CcSEcCtD
Sevoflurane—Amblyopia—Doxorubicin—bone cancer	0.00124	0.0063	CcSEcCtD
Sevoflurane—Pancreatitis—Cisplatin—bone cancer	0.00124	0.0063	CcSEcCtD
Sevoflurane—Bone disorder—Methotrexate—bone cancer	0.00122	0.00622	CcSEcCtD
Sevoflurane—Hyperbilirubinaemia—Methotrexate—bone cancer	0.00121	0.00618	CcSEcCtD
Sevoflurane—Oliguria—Methotrexate—bone cancer	0.0012	0.00609	CcSEcCtD
Sevoflurane—Glycosuria—Doxorubicin—bone cancer	0.00118	0.006	CcSEcCtD
Sevoflurane—Bone disorder—Epirubicin—bone cancer	0.00114	0.00582	CcSEcCtD
Sevoflurane—Ventricular extrasystoles—Epirubicin—bone cancer	0.00114	0.00582	CcSEcCtD
Sevoflurane—Hyperbilirubinaemia—Epirubicin—bone cancer	0.00114	0.00578	CcSEcCtD
Sevoflurane—Cough increased—Epirubicin—bone cancer	0.00113	0.00574	CcSEcCtD
Sevoflurane—Respiratory failure—Methotrexate—bone cancer	0.00112	0.00572	CcSEcCtD
Sevoflurane—Oliguria—Epirubicin—bone cancer	0.00112	0.0057	CcSEcCtD
Sevoflurane—Renal failure—Cisplatin—bone cancer	0.00111	0.00563	CcSEcCtD
Sevoflurane—Conjunctivitis—Cisplatin—bone cancer	0.00109	0.00557	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Cisplatin—bone cancer	0.00106	0.00541	CcSEcCtD
Sevoflurane—Bone disorder—Doxorubicin—bone cancer	0.00106	0.00538	CcSEcCtD
Sevoflurane—Ventricular extrasystoles—Doxorubicin—bone cancer	0.00106	0.00538	CcSEcCtD
Sevoflurane—Hyperbilirubinaemia—Doxorubicin—bone cancer	0.00105	0.00535	CcSEcCtD
Sevoflurane—Cough increased—Doxorubicin—bone cancer	0.00104	0.00531	CcSEcCtD
Sevoflurane—Oliguria—Doxorubicin—bone cancer	0.00104	0.00528	CcSEcCtD
Sevoflurane—Ventricular tachycardia—Epirubicin—bone cancer	0.00103	0.00526	CcSEcCtD
Sevoflurane—Hiccups—Epirubicin—bone cancer	0.00103	0.00526	CcSEcCtD
Sevoflurane—Bradycardia—Cisplatin—bone cancer	0.00103	0.00523	CcSEcCtD
Sevoflurane—Dermatitis contact—Epirubicin—bone cancer	0.00102	0.00519	CcSEcCtD
Sevoflurane—Hyperkalaemia—Epirubicin—bone cancer	0.00102	0.00516	CcSEcCtD
Sevoflurane—Salivary hypersecretion—Epirubicin—bone cancer	0.001	0.0051	CcSEcCtD
Sevoflurane—Urinary tract disorder—Cisplatin—bone cancer	0.000998	0.00508	CcSEcCtD
Sevoflurane—Urethral disorder—Cisplatin—bone cancer	0.00099	0.00504	CcSEcCtD
Sevoflurane—Ventricular tachycardia—Doxorubicin—bone cancer	0.000956	0.00486	CcSEcCtD
Sevoflurane—Hiccups—Doxorubicin—bone cancer	0.000956	0.00486	CcSEcCtD
Sevoflurane—Dermatitis contact—Doxorubicin—bone cancer	0.000945	0.00481	CcSEcCtD
Sevoflurane—Hyperkalaemia—Doxorubicin—bone cancer	0.000939	0.00478	CcSEcCtD
Sevoflurane—Cardiac disorder—Cisplatin—bone cancer	0.000938	0.00477	CcSEcCtD
Sevoflurane—Salivary hypersecretion—Doxorubicin—bone cancer	0.000928	0.00472	CcSEcCtD
Sevoflurane—Immune system disorder—Cisplatin—bone cancer	0.000913	0.00464	CcSEcCtD
Sevoflurane—Mediastinal disorder—Cisplatin—bone cancer	0.00091	0.00463	CcSEcCtD
Sevoflurane—Hypertonia—Epirubicin—bone cancer	0.000906	0.00461	CcSEcCtD
Sevoflurane—Arrhythmia—Cisplatin—bone cancer	0.000903	0.00459	CcSEcCtD
Sevoflurane—Hepatic failure—Methotrexate—bone cancer	0.000892	0.00454	CcSEcCtD
Sevoflurane—CYP2A6—Fluoropyrimidine Activity—DHFR—bone cancer	0.000883	0.00671	CbGpPWpGaD
Sevoflurane—CYP2E1—Xenobiotics—CYP3A4—bone cancer	0.000883	0.00671	CbGpPWpGaD
Sevoflurane—Malnutrition—Cisplatin—bone cancer	0.000879	0.00447	CcSEcCtD
Sevoflurane—GABRA4—Orphan transporters—TUBB2A—bone cancer	0.000879	0.00668	CbGpPWpGaD
Sevoflurane—GABRA2—Orphan transporters—TUBB4B—bone cancer	0.000873	0.00663	CbGpPWpGaD
Sevoflurane—Renal failure acute—Methotrexate—bone cancer	0.000868	0.00442	CcSEcCtD
Sevoflurane—GABRB3—Orphan transporters—TUBB4B—bone cancer	0.000867	0.00659	CbGpPWpGaD
Sevoflurane—Hepatic function abnormal—Epirubicin—bone cancer	0.000858	0.00437	CcSEcCtD
Sevoflurane—GABRG2—Orphan transporters—TUBB4B—bone cancer	0.000851	0.00647	CbGpPWpGaD
Sevoflurane—CYP2E1—Tamoxifen metabolism—CYP3A4—bone cancer	0.000849	0.00645	CbGpPWpGaD
Sevoflurane—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000849	0.00645	CbGpPWpGaD
Sevoflurane—Hypertonia—Doxorubicin—bone cancer	0.000838	0.00426	CcSEcCtD
Sevoflurane—Hepatic failure—Epirubicin—bone cancer	0.000834	0.00425	CcSEcCtD
Sevoflurane—Anaphylactoid reaction—Methotrexate—bone cancer	0.000828	0.00421	CcSEcCtD
Sevoflurane—GRIA1—BDNF signaling pathway—EIF2S1—bone cancer	0.000822	0.00625	CbGpPWpGaD
Sevoflurane—Renal failure acute—Epirubicin—bone cancer	0.000812	0.00413	CcSEcCtD
Sevoflurane—CYP2B6—Metapathway biotransformation—CYP4V2—bone cancer	0.000804	0.00611	CbGpPWpGaD
Sevoflurane—GABRB2—Orphan transporters—TUBB2A—bone cancer	0.000804	0.00611	CbGpPWpGaD
Sevoflurane—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000798	0.00607	CbGpPWpGaD
Sevoflurane—Hepatic function abnormal—Doxorubicin—bone cancer	0.000794	0.00404	CcSEcCtD
Sevoflurane—CYP2E1—Metapathway biotransformation—CYP4V2—bone cancer	0.000787	0.00598	CbGpPWpGaD
Sevoflurane—GABRA5—Orphan transporters—TUBB2A—bone cancer	0.000781	0.00593	CbGpPWpGaD
Sevoflurane—Anaphylactoid reaction—Epirubicin—bone cancer	0.000775	0.00394	CcSEcCtD
Sevoflurane—Hepatic failure—Doxorubicin—bone cancer	0.000772	0.00393	CcSEcCtD
Sevoflurane—CYP2A6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000767	0.00583	CbGpPWpGaD
Sevoflurane—GABRA3—Orphan transporters—TUBB2A—bone cancer	0.000767	0.00583	CbGpPWpGaD
Sevoflurane—Convulsion—Cisplatin—bone cancer	0.000762	0.00388	CcSEcCtD
Sevoflurane—GABRA2—Orphan transporters—TUBB2A—bone cancer	0.000753	0.00573	CbGpPWpGaD
Sevoflurane—ATP2C1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000753	0.00572	CbGpPWpGaD
Sevoflurane—Renal failure acute—Doxorubicin—bone cancer	0.000752	0.00382	CcSEcCtD
Sevoflurane—GABRB3—Orphan transporters—TUBB2A—bone cancer	0.000748	0.00569	CbGpPWpGaD
Sevoflurane—GABRA1—Orphan transporters—TUBB4B—bone cancer	0.000744	0.00566	CbGpPWpGaD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000744	0.00378	CcSEcCtD
Sevoflurane—Liver function test abnormal—Methotrexate—bone cancer	0.00074	0.00376	CcSEcCtD
Sevoflurane—GABRG2—Orphan transporters—TUBB2A—bone cancer	0.000735	0.00559	CbGpPWpGaD
Sevoflurane—Anaphylactic shock—Cisplatin—bone cancer	0.000718	0.00365	CcSEcCtD
Sevoflurane—Oedema—Cisplatin—bone cancer	0.000718	0.00365	CcSEcCtD
Sevoflurane—Anaphylactoid reaction—Doxorubicin—bone cancer	0.000717	0.00365	CcSEcCtD
Sevoflurane—Cardiac arrest—Epirubicin—bone cancer	0.000713	0.00363	CcSEcCtD
Sevoflurane—Nervous system disorder—Cisplatin—bone cancer	0.000704	0.00358	CcSEcCtD
Sevoflurane—Thrombocytopenia—Cisplatin—bone cancer	0.000703	0.00358	CcSEcCtD
Sevoflurane—Tachycardia—Cisplatin—bone cancer	0.000701	0.00356	CcSEcCtD
Sevoflurane—Skin disorder—Cisplatin—bone cancer	0.000697	0.00355	CcSEcCtD
Sevoflurane—Liver function test abnormal—Epirubicin—bone cancer	0.000692	0.00352	CcSEcCtD
Sevoflurane—Pancreatitis—Methotrexate—bone cancer	0.000679	0.00345	CcSEcCtD
Sevoflurane—Hypotension—Cisplatin—bone cancer	0.000671	0.00341	CcSEcCtD
Sevoflurane—Cardiac arrest—Doxorubicin—bone cancer	0.00066	0.00336	CcSEcCtD
Sevoflurane—ATP2C1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00065	0.00494	CbGpPWpGaD
Sevoflurane—Dysuria—Methotrexate—bone cancer	0.000648	0.00329	CcSEcCtD
Sevoflurane—GABRA1—Orphan transporters—TUBB2A—bone cancer	0.000642	0.00488	CbGpPWpGaD
Sevoflurane—Liver function test abnormal—Doxorubicin—bone cancer	0.000641	0.00326	CcSEcCtD
Sevoflurane—GLRA1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000641	0.00487	CbGpPWpGaD
Sevoflurane—Dyspnoea—Cisplatin—bone cancer	0.00064	0.00326	CcSEcCtD
Sevoflurane—Pancreatitis—Epirubicin—bone cancer	0.000635	0.00323	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Cisplatin—bone cancer	0.00062	0.00315	CcSEcCtD
Sevoflurane—CYP2B6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000619	0.0047	CbGpPWpGaD
Sevoflurane—Pain—Cisplatin—bone cancer	0.000614	0.00312	CcSEcCtD
Sevoflurane—Renal failure—Methotrexate—bone cancer	0.000607	0.00309	CcSEcCtD
Sevoflurane—Dysuria—Epirubicin—bone cancer	0.000606	0.00308	CcSEcCtD
Sevoflurane—Conjunctivitis—Methotrexate—bone cancer	0.0006	0.00305	CcSEcCtD
Sevoflurane—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—bone cancer	0.000592	0.0045	CbGpPWpGaD
Sevoflurane—Feeling abnormal—Cisplatin—bone cancer	0.000591	0.00301	CcSEcCtD
Sevoflurane—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00059	0.00448	CbGpPWpGaD
Sevoflurane—Pancreatitis—Doxorubicin—bone cancer	0.000588	0.00299	CcSEcCtD
Sevoflurane—Hyperglycaemia—Epirubicin—bone cancer	0.000585	0.00297	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Methotrexate—bone cancer	0.000584	0.00297	CcSEcCtD
Sevoflurane—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000577	0.00439	CbGpPWpGaD
Sevoflurane—Renal failure—Epirubicin—bone cancer	0.000568	0.00289	CcSEcCtD
Sevoflurane—Body temperature increased—Cisplatin—bone cancer	0.000567	0.00289	CcSEcCtD
Sevoflurane—Jaundice—Epirubicin—bone cancer	0.000563	0.00287	CcSEcCtD
Sevoflurane—Conjunctivitis—Epirubicin—bone cancer	0.000562	0.00286	CcSEcCtD
Sevoflurane—Dysuria—Doxorubicin—bone cancer	0.000561	0.00285	CcSEcCtD
Sevoflurane—Haemoglobin—Methotrexate—bone cancer	0.000557	0.00283	CcSEcCtD
Sevoflurane—Haemorrhage—Methotrexate—bone cancer	0.000554	0.00282	CcSEcCtD
Sevoflurane—Hepatitis—Methotrexate—bone cancer	0.000554	0.00282	CcSEcCtD
Sevoflurane—GLRA1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000553	0.0042	CbGpPWpGaD
Sevoflurane—Pharyngitis—Methotrexate—bone cancer	0.00055	0.0028	CcSEcCtD
Sevoflurane—Urinary tract disorder—Methotrexate—bone cancer	0.000547	0.00279	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Epirubicin—bone cancer	0.000547	0.00278	CcSEcCtD
Sevoflurane—Urethral disorder—Methotrexate—bone cancer	0.000543	0.00276	CcSEcCtD
Sevoflurane—Hyperglycaemia—Doxorubicin—bone cancer	0.000541	0.00275	CcSEcCtD
Sevoflurane—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—bone cancer	0.000533	0.00405	CbGpPWpGaD
Sevoflurane—Hypersensitivity—Cisplatin—bone cancer	0.000529	0.00269	CcSEcCtD
Sevoflurane—Bradycardia—Epirubicin—bone cancer	0.000528	0.00269	CcSEcCtD
Sevoflurane—Renal failure—Doxorubicin—bone cancer	0.000526	0.00267	CcSEcCtD
Sevoflurane—Haemoglobin—Epirubicin—bone cancer	0.000521	0.00265	CcSEcCtD
Sevoflurane—Jaundice—Doxorubicin—bone cancer	0.000521	0.00265	CcSEcCtD
Sevoflurane—Conjunctivitis—Doxorubicin—bone cancer	0.00052	0.00264	CcSEcCtD
Sevoflurane—Haemorrhage—Epirubicin—bone cancer	0.000519	0.00264	CcSEcCtD
Sevoflurane—Hepatitis—Epirubicin—bone cancer	0.000519	0.00264	CcSEcCtD
Sevoflurane—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SPARC—bone cancer	0.000515	0.00392	CbGpPWpGaD
Sevoflurane—Asthenia—Cisplatin—bone cancer	0.000515	0.00262	CcSEcCtD
Sevoflurane—Pharyngitis—Epirubicin—bone cancer	0.000515	0.00262	CcSEcCtD
Sevoflurane—Cardiac disorder—Methotrexate—bone cancer	0.000515	0.00262	CcSEcCtD
Sevoflurane—Urinary tract disorder—Epirubicin—bone cancer	0.000512	0.00261	CcSEcCtD
Sevoflurane—Urethral disorder—Epirubicin—bone cancer	0.000509	0.00259	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Doxorubicin—bone cancer	0.000506	0.00257	CcSEcCtD
Sevoflurane—Angiopathy—Methotrexate—bone cancer	0.000503	0.00256	CcSEcCtD
Sevoflurane—Immune system disorder—Methotrexate—bone cancer	0.000501	0.00255	CcSEcCtD
Sevoflurane—Mediastinal disorder—Methotrexate—bone cancer	0.0005	0.00254	CcSEcCtD
Sevoflurane—GRIA1—Amyotrophic lateral sclerosis (ALS)—TP53—bone cancer	0.000498	0.00378	CbGpPWpGaD
Sevoflurane—Chills—Methotrexate—bone cancer	0.000497	0.00253	CcSEcCtD
Sevoflurane—Bradycardia—Doxorubicin—bone cancer	0.000489	0.00249	CcSEcCtD
Sevoflurane—Mental disorder—Methotrexate—bone cancer	0.000486	0.00247	CcSEcCtD
Sevoflurane—Malnutrition—Methotrexate—bone cancer	0.000483	0.00246	CcSEcCtD
Sevoflurane—Haemoglobin—Doxorubicin—bone cancer	0.000482	0.00245	CcSEcCtD
Sevoflurane—Cardiac disorder—Epirubicin—bone cancer	0.000481	0.00245	CcSEcCtD
Sevoflurane—Hepatitis—Doxorubicin—bone cancer	0.00048	0.00244	CcSEcCtD
Sevoflurane—Haemorrhage—Doxorubicin—bone cancer	0.00048	0.00244	CcSEcCtD
Sevoflurane—Pharyngitis—Doxorubicin—bone cancer	0.000476	0.00242	CcSEcCtD
Sevoflurane—Urinary tract disorder—Doxorubicin—bone cancer	0.000474	0.00241	CcSEcCtD
Sevoflurane—Dysgeusia—Methotrexate—bone cancer	0.000473	0.0024	CcSEcCtD
Sevoflurane—Angiopathy—Epirubicin—bone cancer	0.000471	0.00239	CcSEcCtD
Sevoflurane—Urethral disorder—Doxorubicin—bone cancer	0.000471	0.00239	CcSEcCtD
Sevoflurane—Immune system disorder—Epirubicin—bone cancer	0.000469	0.00238	CcSEcCtD
Sevoflurane—Mediastinal disorder—Epirubicin—bone cancer	0.000468	0.00238	CcSEcCtD
Sevoflurane—Chills—Epirubicin—bone cancer	0.000466	0.00237	CcSEcCtD
Sevoflurane—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000464	0.00353	CbGpPWpGaD
Sevoflurane—Arrhythmia—Epirubicin—bone cancer	0.000463	0.00236	CcSEcCtD
Sevoflurane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000459	0.00348	CbGpPWpGaD
Sevoflurane—CYP2A6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000458	0.00348	CbGpPWpGaD
Sevoflurane—Vomiting—Cisplatin—bone cancer	0.000456	0.00232	CcSEcCtD
Sevoflurane—Mental disorder—Epirubicin—bone cancer	0.000455	0.00231	CcSEcCtD
Sevoflurane—CYP2E1—Tryptophan metabolism—CYP3A4—bone cancer	0.000453	0.00345	CbGpPWpGaD
Sevoflurane—Rash—Cisplatin—bone cancer	0.000453	0.0023	CcSEcCtD
Sevoflurane—Dermatitis—Cisplatin—bone cancer	0.000452	0.0023	CcSEcCtD
Sevoflurane—Malnutrition—Epirubicin—bone cancer	0.000452	0.0023	CcSEcCtD
Sevoflurane—ND1—Metabolism—NDUFA12—bone cancer	0.000446	0.00339	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—NDUFA12—bone cancer	0.000446	0.00339	CbGpPWpGaD
Sevoflurane—Cardiac disorder—Doxorubicin—bone cancer	0.000446	0.00227	CcSEcCtD
Sevoflurane—Tension—Epirubicin—bone cancer	0.000443	0.00225	CcSEcCtD
Sevoflurane—Dysgeusia—Epirubicin—bone cancer	0.000442	0.00225	CcSEcCtD
Sevoflurane—Nervousness—Epirubicin—bone cancer	0.000439	0.00223	CcSEcCtD
Sevoflurane—Angiopathy—Doxorubicin—bone cancer	0.000436	0.00222	CcSEcCtD
Sevoflurane—Immune system disorder—Doxorubicin—bone cancer	0.000434	0.00221	CcSEcCtD
Sevoflurane—Mediastinal disorder—Doxorubicin—bone cancer	0.000433	0.0022	CcSEcCtD
Sevoflurane—Chills—Doxorubicin—bone cancer	0.000431	0.00219	CcSEcCtD
Sevoflurane—Arrhythmia—Doxorubicin—bone cancer	0.000429	0.00218	CcSEcCtD
Sevoflurane—Nausea—Cisplatin—bone cancer	0.000426	0.00217	CcSEcCtD
Sevoflurane—Cough—Methotrexate—bone cancer	0.000421	0.00214	CcSEcCtD
Sevoflurane—Mental disorder—Doxorubicin—bone cancer	0.000421	0.00214	CcSEcCtD
Sevoflurane—Convulsion—Methotrexate—bone cancer	0.000418	0.00213	CcSEcCtD
Sevoflurane—Malnutrition—Doxorubicin—bone cancer	0.000418	0.00213	CcSEcCtD
Sevoflurane—Agitation—Epirubicin—bone cancer	0.000415	0.00211	CcSEcCtD
Sevoflurane—Chest pain—Methotrexate—bone cancer	0.000411	0.00209	CcSEcCtD
Sevoflurane—Tension—Doxorubicin—bone cancer	0.00041	0.00209	CcSEcCtD
Sevoflurane—Dysgeusia—Doxorubicin—bone cancer	0.000409	0.00208	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000408	0.00208	CcSEcCtD
Sevoflurane—Nervousness—Doxorubicin—bone cancer	0.000406	0.00206	CcSEcCtD
Sevoflurane—Syncope—Epirubicin—bone cancer	0.000405	0.00206	CcSEcCtD
Sevoflurane—GABRB3—BDNF signaling pathway—EIF2S1—bone cancer	0.000402	0.00306	CbGpPWpGaD
Sevoflurane—Confusional state—Methotrexate—bone cancer	0.000397	0.00202	CcSEcCtD
Sevoflurane—Loss of consciousness—Epirubicin—bone cancer	0.000397	0.00202	CcSEcCtD
Sevoflurane—Cough—Epirubicin—bone cancer	0.000394	0.00201	CcSEcCtD
Sevoflurane—Anaphylactic shock—Methotrexate—bone cancer	0.000394	0.002	CcSEcCtD
Sevoflurane—KCNK18—Neuronal System—BRAF—bone cancer	0.000394	0.00299	CbGpPWpGaD
Sevoflurane—Convulsion—Epirubicin—bone cancer	0.000391	0.00199	CcSEcCtD
Sevoflurane—Hypertension—Epirubicin—bone cancer	0.00039	0.00198	CcSEcCtD
Sevoflurane—Nervous system disorder—Methotrexate—bone cancer	0.000386	0.00197	CcSEcCtD
Sevoflurane—Thrombocytopenia—Methotrexate—bone cancer	0.000386	0.00196	CcSEcCtD
Sevoflurane—Chest pain—Epirubicin—bone cancer	0.000384	0.00196	CcSEcCtD
Sevoflurane—Agitation—Doxorubicin—bone cancer	0.000384	0.00195	CcSEcCtD
Sevoflurane—Skin disorder—Methotrexate—bone cancer	0.000383	0.00195	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000382	0.00194	CcSEcCtD
Sevoflurane—Dry mouth—Epirubicin—bone cancer	0.000376	0.00191	CcSEcCtD
Sevoflurane—CYP2A6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000376	0.00286	CbGpPWpGaD
Sevoflurane—Syncope—Doxorubicin—bone cancer	0.000375	0.00191	CcSEcCtD
Sevoflurane—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000374	0.00284	CbGpPWpGaD
Sevoflurane—Confusional state—Epirubicin—bone cancer	0.000372	0.00189	CcSEcCtD
Sevoflurane—ND1—Metabolism—NT5C3A—bone cancer	0.00037	0.00281	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—NT5C3A—bone cancer	0.00037	0.00281	CbGpPWpGaD
Sevoflurane—CYP2B6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000369	0.00281	CbGpPWpGaD
Sevoflurane—Oedema—Epirubicin—bone cancer	0.000369	0.00188	CcSEcCtD
Sevoflurane—Anaphylactic shock—Epirubicin—bone cancer	0.000369	0.00188	CcSEcCtD
Sevoflurane—Hypotension—Methotrexate—bone cancer	0.000368	0.00187	CcSEcCtD
Sevoflurane—Loss of consciousness—Doxorubicin—bone cancer	0.000367	0.00187	CcSEcCtD
Sevoflurane—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000367	0.00279	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000365	0.00278	CbGpPWpGaD
Sevoflurane—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000365	0.00277	CbGpPWpGaD
Sevoflurane—Cough—Doxorubicin—bone cancer	0.000365	0.00186	CcSEcCtD
Sevoflurane—Shock—Epirubicin—bone cancer	0.000363	0.00184	CcSEcCtD
Sevoflurane—Convulsion—Doxorubicin—bone cancer	0.000362	0.00184	CcSEcCtD
Sevoflurane—CYP2E1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000362	0.00275	CbGpPWpGaD
Sevoflurane—Nervous system disorder—Epirubicin—bone cancer	0.000361	0.00184	CcSEcCtD
Sevoflurane—Thrombocytopenia—Epirubicin—bone cancer	0.000361	0.00184	CcSEcCtD
Sevoflurane—Hypertension—Doxorubicin—bone cancer	0.000361	0.00184	CcSEcCtD
Sevoflurane—Tachycardia—Epirubicin—bone cancer	0.00036	0.00183	CcSEcCtD
Sevoflurane—Skin disorder—Epirubicin—bone cancer	0.000358	0.00182	CcSEcCtD
Sevoflurane—Insomnia—Methotrexate—bone cancer	0.000356	0.00181	CcSEcCtD
Sevoflurane—Chest pain—Doxorubicin—bone cancer	0.000356	0.00181	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000353	0.0018	CcSEcCtD
Sevoflurane—Dyspnoea—Methotrexate—bone cancer	0.000351	0.00179	CcSEcCtD
Sevoflurane—Somnolence—Methotrexate—bone cancer	0.00035	0.00178	CcSEcCtD
Sevoflurane—Dry mouth—Doxorubicin—bone cancer	0.000348	0.00177	CcSEcCtD
Sevoflurane—ALB—Folate Metabolism—DHFR—bone cancer	0.000345	0.00262	CbGpPWpGaD
Sevoflurane—Hypotension—Epirubicin—bone cancer	0.000344	0.00175	CcSEcCtD
Sevoflurane—Confusional state—Doxorubicin—bone cancer	0.000344	0.00175	CcSEcCtD
Sevoflurane—Anaphylactic shock—Doxorubicin—bone cancer	0.000341	0.00174	CcSEcCtD
Sevoflurane—Oedema—Doxorubicin—bone cancer	0.000341	0.00174	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Methotrexate—bone cancer	0.00034	0.00173	CcSEcCtD
Sevoflurane—Pain—Methotrexate—bone cancer	0.000337	0.00171	CcSEcCtD
Sevoflurane—Shock—Doxorubicin—bone cancer	0.000336	0.00171	CcSEcCtD
Sevoflurane—Nervous system disorder—Doxorubicin—bone cancer	0.000334	0.0017	CcSEcCtD
Sevoflurane—Thrombocytopenia—Doxorubicin—bone cancer	0.000334	0.0017	CcSEcCtD
Sevoflurane—Insomnia—Epirubicin—bone cancer	0.000333	0.0017	CcSEcCtD
Sevoflurane—Tachycardia—Doxorubicin—bone cancer	0.000333	0.00169	CcSEcCtD
Sevoflurane—Skin disorder—Doxorubicin—bone cancer	0.000331	0.00169	CcSEcCtD
Sevoflurane—KCNK18—Neuronal System—MDM2—bone cancer	0.00033	0.00251	CbGpPWpGaD
Sevoflurane—Dyspnoea—Epirubicin—bone cancer	0.000329	0.00167	CcSEcCtD
Sevoflurane—GABRQ—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000328	0.00249	CbGpPWpGaD
Sevoflurane—Somnolence—Epirubicin—bone cancer	0.000328	0.00167	CcSEcCtD
Sevoflurane—Feeling abnormal—Methotrexate—bone cancer	0.000325	0.00165	CcSEcCtD
Sevoflurane—KCNK10—Neuronal System—BRAF—bone cancer	0.000321	0.00244	CbGpPWpGaD
Sevoflurane—Hypotension—Doxorubicin—bone cancer	0.000319	0.00162	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Epirubicin—bone cancer	0.000318	0.00162	CcSEcCtD
Sevoflurane—Pain—Epirubicin—bone cancer	0.000315	0.0016	CcSEcCtD
Sevoflurane—Urticaria—Methotrexate—bone cancer	0.000313	0.00159	CcSEcCtD
Sevoflurane—Body temperature increased—Methotrexate—bone cancer	0.000311	0.00158	CcSEcCtD
Sevoflurane—KCNA1—Neuronal System—BRAF—bone cancer	0.000311	0.00237	CbGpPWpGaD
Sevoflurane—Insomnia—Doxorubicin—bone cancer	0.000308	0.00157	CcSEcCtD
Sevoflurane—KCNK2—Neuronal System—BRAF—bone cancer	0.000307	0.00233	CbGpPWpGaD
Sevoflurane—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000306	0.00232	CbGpPWpGaD
Sevoflurane—Dyspnoea—Doxorubicin—bone cancer	0.000304	0.00155	CcSEcCtD
Sevoflurane—Feeling abnormal—Epirubicin—bone cancer	0.000304	0.00155	CcSEcCtD
Sevoflurane—CYP2B6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000303	0.00231	CbGpPWpGaD
Sevoflurane—Somnolence—Doxorubicin—bone cancer	0.000303	0.00154	CcSEcCtD
Sevoflurane—ALB—Platelet degranulation—SPARC—bone cancer	0.000302	0.00229	CbGpPWpGaD
Sevoflurane—KCNK3—Neuronal System—BRAF—bone cancer	0.000298	0.00227	CbGpPWpGaD
Sevoflurane—KCNK9—Neuronal System—BRAF—bone cancer	0.000298	0.00227	CbGpPWpGaD
Sevoflurane—CYP2E1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000297	0.00226	CbGpPWpGaD
Sevoflurane—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000294	0.0015	CcSEcCtD
Sevoflurane—Urticaria—Epirubicin—bone cancer	0.000293	0.00149	CcSEcCtD
Sevoflurane—Pain—Doxorubicin—bone cancer	0.000292	0.00148	CcSEcCtD
Sevoflurane—Body temperature increased—Epirubicin—bone cancer	0.000291	0.00148	CcSEcCtD
Sevoflurane—Hypersensitivity—Methotrexate—bone cancer	0.00029	0.00148	CcSEcCtD
Sevoflurane—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—bone cancer	0.000288	0.00219	CbGpPWpGaD
Sevoflurane—GABRQ—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000283	0.00215	CbGpPWpGaD
Sevoflurane—Asthenia—Methotrexate—bone cancer	0.000283	0.00144	CcSEcCtD
Sevoflurane—Feeling abnormal—Doxorubicin—bone cancer	0.000281	0.00143	CcSEcCtD
Sevoflurane—Pruritus—Methotrexate—bone cancer	0.000279	0.00142	CcSEcCtD
Sevoflurane—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000277	0.0021	CbGpPWpGaD
Sevoflurane—GRIA1—Transmission across Chemical Synapses—BRAF—bone cancer	0.000274	0.00209	CbGpPWpGaD
Sevoflurane—Hypersensitivity—Epirubicin—bone cancer	0.000272	0.00138	CcSEcCtD
Sevoflurane—Urticaria—Doxorubicin—bone cancer	0.000271	0.00138	CcSEcCtD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00027	0.00205	CbGpPWpGaD
Sevoflurane—Body temperature increased—Doxorubicin—bone cancer	0.00027	0.00137	CcSEcCtD
Sevoflurane—KCNK10—Neuronal System—MDM2—bone cancer	0.000269	0.00204	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000266	0.00202	CbGpPWpGaD
Sevoflurane—Asthenia—Epirubicin—bone cancer	0.000264	0.00135	CcSEcCtD
Sevoflurane—Pruritus—Epirubicin—bone cancer	0.000261	0.00133	CcSEcCtD
Sevoflurane—KCNA1—Neuronal System—MDM2—bone cancer	0.000261	0.00198	CbGpPWpGaD
Sevoflurane—Dizziness—Methotrexate—bone cancer	0.00026	0.00133	CcSEcCtD
Sevoflurane—GRIA1—BDNF signaling pathway—JUN—bone cancer	0.00026	0.00198	CbGpPWpGaD
Sevoflurane—KCNK2—Neuronal System—MDM2—bone cancer	0.000257	0.00195	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000252	0.00191	CbGpPWpGaD
Sevoflurane—Hypersensitivity—Doxorubicin—bone cancer	0.000251	0.00128	CcSEcCtD
Sevoflurane—Vomiting—Methotrexate—bone cancer	0.00025	0.00127	CcSEcCtD
Sevoflurane—KCNK3—Neuronal System—MDM2—bone cancer	0.00025	0.0019	CbGpPWpGaD
Sevoflurane—KCNK9—Neuronal System—MDM2—bone cancer	0.00025	0.0019	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000248	0.00189	CbGpPWpGaD
Sevoflurane—Rash—Methotrexate—bone cancer	0.000248	0.00126	CcSEcCtD
Sevoflurane—Dermatitis—Methotrexate—bone cancer	0.000248	0.00126	CcSEcCtD
Sevoflurane—Headache—Methotrexate—bone cancer	0.000247	0.00126	CcSEcCtD
Sevoflurane—Asthenia—Doxorubicin—bone cancer	0.000245	0.00124	CcSEcCtD
Sevoflurane—Dizziness—Epirubicin—bone cancer	0.000244	0.00124	CcSEcCtD
Sevoflurane—Pruritus—Doxorubicin—bone cancer	0.000241	0.00123	CcSEcCtD
Sevoflurane—Vomiting—Epirubicin—bone cancer	0.000234	0.00119	CcSEcCtD
Sevoflurane—Nausea—Methotrexate—bone cancer	0.000234	0.00119	CcSEcCtD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000233	0.00177	CbGpPWpGaD
Sevoflurane—Rash—Epirubicin—bone cancer	0.000232	0.00118	CcSEcCtD
Sevoflurane—Dermatitis—Epirubicin—bone cancer	0.000232	0.00118	CcSEcCtD
Sevoflurane—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000232	0.00176	CbGpPWpGaD
Sevoflurane—Headache—Epirubicin—bone cancer	0.000231	0.00117	CcSEcCtD
Sevoflurane—GRIA1—Transmission across Chemical Synapses—MDM2—bone cancer	0.00023	0.00175	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00023	0.00174	CbGpPWpGaD
Sevoflurane—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000228	0.00173	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000227	0.00173	CbGpPWpGaD
Sevoflurane—Dizziness—Doxorubicin—bone cancer	0.000226	0.00115	CcSEcCtD
Sevoflurane—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000224	0.00171	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000221	0.00168	CbGpPWpGaD
Sevoflurane—Nausea—Epirubicin—bone cancer	0.000219	0.00111	CcSEcCtD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000217	0.00165	CbGpPWpGaD
Sevoflurane—Vomiting—Doxorubicin—bone cancer	0.000217	0.0011	CcSEcCtD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000217	0.00165	CbGpPWpGaD
Sevoflurane—Rash—Doxorubicin—bone cancer	0.000215	0.00109	CcSEcCtD
Sevoflurane—Dermatitis—Doxorubicin—bone cancer	0.000215	0.00109	CcSEcCtD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000215	0.00163	CbGpPWpGaD
Sevoflurane—Headache—Doxorubicin—bone cancer	0.000214	0.00109	CcSEcCtD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000213	0.00162	CbGpPWpGaD
Sevoflurane—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000212	0.00161	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000212	0.00161	CbGpPWpGaD
Sevoflurane—GRIA1—Neuronal System—BRAF—bone cancer	0.00021	0.0016	CbGpPWpGaD
Sevoflurane—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.00021	0.00159	CbGpPWpGaD
Sevoflurane—CYP2E1—Tryptophan metabolism—MDM2—bone cancer	0.000208	0.00158	CbGpPWpGaD
Sevoflurane—GABRQ—Transmission across Chemical Synapses—BRAF—bone cancer	0.000208	0.00158	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000208	0.00158	CbGpPWpGaD
Sevoflurane—Nausea—Doxorubicin—bone cancer	0.000203	0.00103	CcSEcCtD
Sevoflurane—CYP2A6—Biological oxidations—CYP3A4—bone cancer	0.0002	0.00152	CbGpPWpGaD
Sevoflurane—CYP2A6—Fluoropyrimidine Activity—TP53—bone cancer	0.000197	0.0015	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000196	0.00149	CbGpPWpGaD
Sevoflurane—CYP2A6—NRF2 pathway—GSTP1—bone cancer	0.000195	0.00148	CbGpPWpGaD
Sevoflurane—CYP2A6—NRF2 pathway—TGFBR2—bone cancer	0.000195	0.00148	CbGpPWpGaD
Sevoflurane—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000192	0.00146	CbGpPWpGaD
Sevoflurane—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000191	0.00145	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000191	0.00145	CbGpPWpGaD
Sevoflurane—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000188	0.00143	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000187	0.00142	CbGpPWpGaD
Sevoflurane—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000186	0.00142	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000184	0.0014	CbGpPWpGaD
Sevoflurane—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000183	0.00139	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000183	0.00139	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000182	0.00138	CbGpPWpGaD
Sevoflurane—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.00018	0.00137	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000179	0.00136	CbGpPWpGaD
Sevoflurane—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000179	0.00136	CbGpPWpGaD
Sevoflurane—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000178	0.00135	CbGpPWpGaD
Sevoflurane—GRIA1—Neuronal System—MDM2—bone cancer	0.000176	0.00134	CbGpPWpGaD
Sevoflurane—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000176	0.00133	CbGpPWpGaD
Sevoflurane—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000175	0.00133	CbGpPWpGaD
Sevoflurane—GABRQ—Transmission across Chemical Synapses—MDM2—bone cancer	0.000174	0.00132	CbGpPWpGaD
Sevoflurane—GABRG3—Transmission across Chemical Synapses—BRAF—bone cancer	0.000171	0.0013	CbGpPWpGaD
Sevoflurane—CYP2A6—Biological oxidations—GSTP1—bone cancer	0.000171	0.0013	CbGpPWpGaD
Sevoflurane—GABRB1—Transmission across Chemical Synapses—BRAF—bone cancer	0.000169	0.00128	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—ENO2—bone cancer	0.000162	0.00123	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—ENO2—bone cancer	0.000162	0.00123	CbGpPWpGaD
Sevoflurane—CYP2B6—Biological oxidations—CYP3A4—bone cancer	0.000161	0.00122	CbGpPWpGaD
Sevoflurane—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000161	0.00122	CbGpPWpGaD
Sevoflurane—GABRA6—Transmission across Chemical Synapses—BRAF—bone cancer	0.00016	0.00121	CbGpPWpGaD
Sevoflurane—GABRQ—Neuronal System—BRAF—bone cancer	0.000159	0.00121	CbGpPWpGaD
Sevoflurane—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	0.000159	0.00121	CbGpPWpGaD
Sevoflurane—CYP2E1—Biological oxidations—CYP3A4—bone cancer	0.000158	0.0012	CbGpPWpGaD
Sevoflurane—GABRA4—Transmission across Chemical Synapses—BRAF—bone cancer	0.000158	0.0012	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000157	0.00119	CbGpPWpGaD
Sevoflurane—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000156	0.00119	CbGpPWpGaD
Sevoflurane—CYP2E1—Metapathway biotransformation—CYP3A4—bone cancer	0.000156	0.00118	CbGpPWpGaD
Sevoflurane—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000153	0.00116	CbGpPWpGaD
Sevoflurane—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000153	0.00116	CbGpPWpGaD
Sevoflurane—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000151	0.00114	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—DHFR—bone cancer	0.00015	0.00114	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—DHFR—bone cancer	0.00015	0.00114	CbGpPWpGaD
Sevoflurane—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.00015	0.00114	CbGpPWpGaD
Sevoflurane—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000147	0.00112	CbGpPWpGaD
Sevoflurane—GABRB2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000144	0.0011	CbGpPWpGaD
Sevoflurane—GABRG3—Transmission across Chemical Synapses—MDM2—bone cancer	0.000143	0.00109	CbGpPWpGaD
Sevoflurane—GABRB1—Transmission across Chemical Synapses—MDM2—bone cancer	0.000141	0.00107	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—GNA11—bone cancer	0.00014	0.00107	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—GNA11—bone cancer	0.00014	0.00107	CbGpPWpGaD
Sevoflurane—GABRA5—Transmission across Chemical Synapses—BRAF—bone cancer	0.00014	0.00106	CbGpPWpGaD
Sevoflurane—CYP2B6—Biological oxidations—GSTP1—bone cancer	0.000138	0.00105	CbGpPWpGaD
Sevoflurane—GABRA3—Transmission across Chemical Synapses—BRAF—bone cancer	0.000137	0.00104	CbGpPWpGaD
Sevoflurane—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	0.000136	0.00103	CbGpPWpGaD
Sevoflurane—GABRA2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000135	0.00103	CbGpPWpGaD
Sevoflurane—CYP2E1—Biological oxidations—GSTP1—bone cancer	0.000135	0.00103	CbGpPWpGaD
Sevoflurane—GABRB3—Transmission across Chemical Synapses—BRAF—bone cancer	0.000134	0.00102	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—SPARC—bone cancer	0.000134	0.00102	CbGpPWpGaD
Sevoflurane—GABRA6—Transmission across Chemical Synapses—MDM2—bone cancer	0.000134	0.00102	CbGpPWpGaD
Sevoflurane—GABRQ—Neuronal System—MDM2—bone cancer	0.000133	0.00101	CbGpPWpGaD
Sevoflurane—CYP2E1—Metapathway biotransformation—GSTP1—bone cancer	0.000133	0.00101	CbGpPWpGaD
Sevoflurane—GABRA4—Transmission across Chemical Synapses—MDM2—bone cancer	0.000132	0.001	CbGpPWpGaD
Sevoflurane—GABRG2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000132	0.001	CbGpPWpGaD
Sevoflurane—GABRG3—Neuronal System—BRAF—bone cancer	0.000131	0.000997	CbGpPWpGaD
Sevoflurane—GABRB1—Neuronal System—BRAF—bone cancer	0.000129	0.000982	CbGpPWpGaD
Sevoflurane—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000128	0.000976	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—CYP3A4—bone cancer	0.000127	0.000968	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—CYP3A4—bone cancer	0.000127	0.000968	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—JUN—bone cancer	0.000127	0.000966	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—GNA11—bone cancer	0.000122	0.000931	CbGpPWpGaD
Sevoflurane—GABRA6—Neuronal System—BRAF—bone cancer	0.000122	0.000929	CbGpPWpGaD
Sevoflurane—GABRB2—Transmission across Chemical Synapses—MDM2—bone cancer	0.000121	0.000918	CbGpPWpGaD
Sevoflurane—GABRA4—Neuronal System—BRAF—bone cancer	0.000121	0.000918	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—NDUFA12—bone cancer	0.00012	0.00091	CbGpPWpGaD
Sevoflurane—GABRA5—Transmission across Chemical Synapses—MDM2—bone cancer	0.000117	0.000892	CbGpPWpGaD
Sevoflurane—GABRA1—Transmission across Chemical Synapses—BRAF—bone cancer	0.000115	0.000876	CbGpPWpGaD
Sevoflurane—GABRA3—Transmission across Chemical Synapses—MDM2—bone cancer	0.000115	0.000876	CbGpPWpGaD
Sevoflurane—GABRA2—Transmission across Chemical Synapses—MDM2—bone cancer	0.000113	0.00086	CbGpPWpGaD
Sevoflurane—GABRB3—Transmission across Chemical Synapses—MDM2—bone cancer	0.000112	0.000855	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—IL3—bone cancer	0.000111	0.000844	CbGpPWpGaD
Sevoflurane—GABRG2—Transmission across Chemical Synapses—MDM2—bone cancer	0.00011	0.000839	CbGpPWpGaD
Sevoflurane—GABRB2—Neuronal System—BRAF—bone cancer	0.00011	0.000839	CbGpPWpGaD
Sevoflurane—GABRG3—Neuronal System—MDM2—bone cancer	0.00011	0.000835	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—GSTP1—bone cancer	0.000109	0.000828	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—GSTP1—bone cancer	0.000109	0.000828	CbGpPWpGaD
Sevoflurane—GABRB1—Neuronal System—MDM2—bone cancer	0.000108	0.000823	CbGpPWpGaD
Sevoflurane—GABRA5—Neuronal System—BRAF—bone cancer	0.000107	0.000815	CbGpPWpGaD
Sevoflurane—GABRA3—Neuronal System—BRAF—bone cancer	0.000105	0.000801	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000104	0.00079	CbGpPWpGaD
Sevoflurane—GABRA2—Neuronal System—BRAF—bone cancer	0.000104	0.000787	CbGpPWpGaD
Sevoflurane—GABRB3—Neuronal System—BRAF—bone cancer	0.000103	0.000782	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—PTGS2—bone cancer	0.000103	0.000781	CbGpPWpGaD
Sevoflurane—GABRA6—Neuronal System—MDM2—bone cancer	0.000102	0.000779	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—JUN—bone cancer	0.000102	0.000778	CbGpPWpGaD
Sevoflurane—GABRA4—Neuronal System—MDM2—bone cancer	0.000101	0.000769	CbGpPWpGaD
Sevoflurane—GABRG2—Neuronal System—BRAF—bone cancer	0.000101	0.000768	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—NT5C3A—bone cancer	9.92e-05	0.000754	CbGpPWpGaD
Sevoflurane—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	9.67e-05	0.000735	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—NDUFA12—bone cancer	9.66e-05	0.000734	CbGpPWpGaD
Sevoflurane—GABRA1—Transmission across Chemical Synapses—MDM2—bone cancer	9.65e-05	0.000734	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—NDUFA12—bone cancer	9.46e-05	0.000719	CbGpPWpGaD
Sevoflurane—GABRB2—Neuronal System—MDM2—bone cancer	9.25e-05	0.000703	CbGpPWpGaD
Sevoflurane—GABRA5—Neuronal System—MDM2—bone cancer	8.99e-05	0.000683	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—TUBB2A—bone cancer	8.98e-05	0.000682	CbGpPWpGaD
Sevoflurane—GABRA1—Neuronal System—BRAF—bone cancer	8.83e-05	0.000671	CbGpPWpGaD
Sevoflurane—GABRA3—Neuronal System—MDM2—bone cancer	8.83e-05	0.000671	CbGpPWpGaD
Sevoflurane—GABRA2—Neuronal System—MDM2—bone cancer	8.67e-05	0.000659	CbGpPWpGaD
Sevoflurane—GABRB3—Neuronal System—MDM2—bone cancer	8.62e-05	0.000655	CbGpPWpGaD
Sevoflurane—GABRG2—Neuronal System—MDM2—bone cancer	8.46e-05	0.000643	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—NDUFA12—bone cancer	8.13e-05	0.000618	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—NT5C3A—bone cancer	8e-05	0.000608	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—NT5C3A—bone cancer	7.84e-05	0.000596	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—TP53—bone cancer	7.7e-05	0.000585	CbGpPWpGaD
Sevoflurane—GABRA1—Neuronal System—MDM2—bone cancer	7.4e-05	0.000562	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—SPARC—bone cancer	6.9e-05	0.000524	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—NT5C3A—bone cancer	6.74e-05	0.000512	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—GNA11—bone cancer	6.31e-05	0.00048	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—GSTP1—bone cancer	6.26e-05	0.000476	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	6.18e-05	0.000469	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—IL3—bone cancer	5.72e-05	0.000435	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PTGS2—bone cancer	5.64e-05	0.000429	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PTGS2—bone cancer	5.64e-05	0.000429	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—NDUFA12—bone cancer	4.39e-05	0.000334	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ENO2—bone cancer	4.35e-05	0.00033	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—DHFR—bone cancer	4.03e-05	0.000306	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GNA11—bone cancer	3.77e-05	0.000286	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PLAU—bone cancer	3.75e-05	0.000285	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—NT5C3A—bone cancer	3.64e-05	0.000276	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ENO2—bone cancer	3.51e-05	0.000266	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ENO2—bone cancer	3.43e-05	0.000261	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CYP3A4—bone cancer	3.42e-05	0.00026	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—DHFR—bone cancer	3.25e-05	0.000247	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—DHFR—bone cancer	3.19e-05	0.000242	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GNA11—bone cancer	3.04e-05	0.000231	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GNA11—bone cancer	2.98e-05	0.000226	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ENO2—bone cancer	2.95e-05	0.000224	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GSTP1—bone cancer	2.92e-05	0.000222	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CYP3A4—bone cancer	2.76e-05	0.000209	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—DHFR—bone cancer	2.74e-05	0.000208	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CYP3A4—bone cancer	2.7e-05	0.000205	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GNA11—bone cancer	2.56e-05	0.000194	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GSTP1—bone cancer	2.36e-05	0.000179	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CYP3A4—bone cancer	2.32e-05	0.000176	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GSTP1—bone cancer	2.31e-05	0.000175	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.31e-05	0.000175	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSTP1—bone cancer	1.98e-05	0.000151	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ENO2—bone cancer	1.59e-05	0.000121	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PTGS2—bone cancer	1.51e-05	0.000115	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—TP53—bone cancer	1.51e-05	0.000115	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—DHFR—bone cancer	1.48e-05	0.000112	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GNA11—bone cancer	1.38e-05	0.000105	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PTGS2—bone cancer	1.22e-05	9.28e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PTGS2—bone cancer	1.2e-05	9.09e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTP1—bone cancer	1.07e-05	8.14e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PTGS2—bone cancer	1.03e-05	7.81e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PTGS2—bone cancer	5.55e-06	4.22e-05	CbGpPWpGaD
